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miR-582-5P induces colorectal cancer cell
proliferation by targeting adenomatous
polyposis coli
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Abstract
Background: microRNA (miRNAs) dysregulation is widely involved in cancer progression and contributed to
sustained cell proliferation by directly targeting multiple targets. Therefore, better understand the underlying
mechanism of miRNA in carcinogenesis may improve diagnostic and therapeutic strategies for malignancy.
Methods: We assessed microRNA-582 (miR-582-5P) expression in colorectal cancer (CRC) specimens and cell lines
by real-time PCR. Luciferase reporter assay was used to confirm the target associations. Colony formation assay and
anchorage-independent growth assay were used to analyze the effect of miR-582-5P on cell proliferation. Adenomatous
polyposis coli (APC) gene and protein expression were examined using real-time PCR and western blotting, respectively.
Results: miR-582-5P was upregulated in the CRC specimens and cell lines and targeted the 3′ untranslated region of APC
directly. miR-582-5P overexpression increased cyclin D1 and c-MYC expression, which subsequently induced CRC cell
proliferation in an APC-dependent manner.
Conclusions: Our findings suggest that miR-582-5P plays an important role in the progression of CRC by inducing
proliferation and may identify new targets for anti-cancer treatment.
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Background
Colorectal cancer (CRC) is one of the most prevalent
malignant cancers and affects men and women almost
equally. Currently, approximately 1.25 million people in
China are diagnosed with CRC, and the incidence of
CRC increases annually and it will continue to rise in
the next few years [1]. Furthermore, CRC is a major
cause of cancer-associated mortality, and more than
600,000 patients will die from it every year worldwide
[2]. In the USA and Europe, CRC is the second most fre-
quent cancer that leads to death [3]. In recent years, sig-
nificant advances have been made in targeted therapies
of CRC. However, better targeted drugs are required be-
cause the effects of existing drugs are not satisfactory.
The adenomatous polyposis coli (APC) gene located at
5q21–q22 encodes a tumor suppressor protein that acts
as an antagonist of the Wnt/β-catenin pathway, which
controls the CRC cell fate during the maintenance phase
of tumors in patients [4, 5]. It is also involved in other
processes, including cell cycle control and cell migration,
adhesion, differentiation, apoptosis, and transcriptional ac-
tivation [4]. Defects in this gene may cause familial aden-
omatous polyposis, an autosomal dominant pre-malignant
disease that usually progresses to malignancy. APC muta-
tion has been found in over 80 % of CRC cases and signifi-
cantly less frequently in sporadic high microsatellite
instability cancers than in low microsatellite instability or
microsatellite instability cancers [6]. Furthermore, APC
mutation-induced upregulation of the survivin/ABK cas-
cade is associated with crypt cell maturation, expansion of
proliferative cell populations, and promotion of tumori-
genesis [7].
microRNAs (miRNAs) are a class of endogenous, small,
non-coding RNAs involved in multiple biological pro-
cesses. They negatively regulate post-transcriptional gene
expression to act as tumor suppressors or oncogenes by
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binding to the 3′ untranslated region (UTR) of a target
gene [8–11]. miRNAs have been widely proposed as po-
tential targets for anti-cancer therapies because a number
of findings have indicated that some miRNAs, such as
miR-150 [12, 13], miR-153 [13], miR-561 [14], and miR-
622 [15], are involved in the development of human CRC.
Publicly available algorithms have indicated that miR-582-
5P may directly target the 3′ UTR of APC. miR-582-5P re-
duces the proliferation and invasion of human bladder
cancer by suppressing the expression of target genes such
as protein geranylgeranyltransferase type I beta subunit
(PGGT1B), leucine-rich repeat kinase 2 (LRRK2), and DIX
domain containing 1 (DIXDC1) [16]. However, the role of
miR-582-5P in CRC progression has not been determined.
In this study, we searched for the possible relationship be-
tween miR-582-5P and APC and the role of miR-582-5P
in the development of CRC.
Methods
Patients and tissues
The eight malignant CRC tissues and matched adjacent
noncancerous tissues used in this study were obtained
from patients who had undergone surgery at the China-
Japan Union Hospital of Jilin University of the People’s
Republic of China. The CRC tissues and matched adja-
cent noncancerous tissues were frozen and stored in li-
quid nitrogen until used.
Cell culture
A normal colonic mucosal epithelial cell line (normal
control) was isolated and purified from the adjacent
noncancerous tissues obtained from the patients. The
human CRC cell lines HT29, SW403, SW480, COLO205,
SW620, COLO320DM, and KM202L were purchased
from American Type Culture Collection (Manassas, VA,
USA) and cultured in Dulbecco’s modified Eagle’s medium
(Invitrogen, Carlsbad, CA, USA) supplemented with 10 %
fetal bovine serum (Invitrogen) at 37 °C in a 5 % CO2 at-
mosphere in a humidified incubator.
Plasmids and transfection
The human APC 3′ UTR was PCR-amplified from gen-
omic DNA from SW480 cells and cloned into pGL3 vectors
(Promega, Madison, WI, USA). Transfection of miR-582-
5P mimic, miR-582-5P inhibitor (miR-582-5P-in), negative
control (NC), NC inhibitor (NC-in) (RiboBio, Guangzhou,
China), and plasmids was performed using Lipofecta-
mine 2000 (Invitrogen) according to the manufac-
turer’s instructions.
RNA extraction and real-time quantitative PCR
Total miRNA from cultured cells and cancer tissue samples
was extracted using the mirVana miRNA Isolation Kit
(Ambion, Austin, TX, USA) according to the manufacturer’s
manual. The expression level of miR-582-5P was performed
using miR-582-5P-specific primer and probe (TaqMan
MicroRNA Assay Kit; Applied Biosystems, Foster City, CA,
USA) on an ABI 7900 system (Applied Biosystems). The
expression of miR-582-5P was defined based on Ct, and
relative expression levels were calculated as 2−[(Ct of miR-582-
5p)− (Ct of U6)] after normalization with reference to the
quantification of U6 small nuclear RNA expression. The fol-
lowing primers (RiboBio, Guangzhou, China) were synthe-
sized and used in this study: GAPDH forward: 5′-A
ATCTCCACTTTGCCACTG-3′, GAPDH reverse: 5′-C
CTCGTCCCGTAGACAAAA-3′; cyclin D1 forward: 5′-A
GGAGAACAAACAGATCA-3′, cyclin D1 reverse: 5′-T
AGGACAGGAAGTTGTTG-3′; and c-MYC forward: 5′-T
CAAGAGGTGCCACGTCTCC-3′, c-MYC reverse: 5′-T
CTTGGCAGCAGGATAGTCCTT-3′.
Western blotting
Western blotting was performed according to a previously
reported method [17]. The membranes were probed with
polyclonal mouse antibodies: anti-APC (ab15270; 1:1000;
Abcam, Cambridge, UK), anti-cyclin D1 (1:1000; Cell Sig-
naling Technology, Danvers, MA, USA), and anti-c-MYC
(1:1000; Cell Signaling Technology). The membranes were
stripped and re-probed with anti-α-tubulin mouse mono-
clonal antibody (1:1000; Cell Signaling Technology) as the
loading control.
Luciferase assay
Cells were seeded in 24-well plates and allowed to settle
for 24 h. PGL3-APC-luciferase plasmid or pGL3-Mut-
luciferase plasmid (100 ng) was transfected into CRC cells
using Lipofectamine 2000 according to the manufacturer’s
instructions. Luciferase and control signals were measured
48 h after transfection using a Dual Luciferase Reporter
Assay Kit (Promega) according to a protocol provided by
the manufacturer. Three independent experiments were
performed, and the data are presented as the mean ± SD.
3-(4,5-Dimethyl-2-thiazolyl)-2, 5-diphenyl-2H-tetrazolium
bromide assay
Cells were seeded on 96-well plates and stained at the indi-
cated time points with 100 μl sterile 3-(4,5-dimethyl-2-
thiazolyl)-2, 5-diphenyl-2H-tetrazolium bromide (MTT)
dye (0.5 mg/ml, Invitrogen) for 4 h at 37 °C, followed by
the removal of the culture medium and the addition of di-
methyl sulfoxide (Sigma-Aldrich, St. Louis, MO, USA).
The absorbance at 450 nm was measured using a micro-
plate reader (Bio-Rad, La Jolla, CA, USA). Three inde-
pendent repeat experiments were performed, and the data
are presented as the mean ± SD.
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Colony formation assay
Cells were seeded on a 6-well plate (1 × 103 cells per
well) and cultured for 10 days. The colonies were stained
with 1.0 % crystal violet for 5 min after a 15-min fixation
with 10 % formaldehyde. All experiments were per-
formed in triplicates.
Anchorage-independent growth assay
Five hundred cells were trypsinized and suspended in 2 ml
complete medium plus 0.3 % agar (Sigma-Aldrich). The
agar-cell mixture was plated on top of a bottom layer con-
taining 1 % complete medium agar mixture. After 10 days,
viable colonies that were larger than 0.1 mm (diameter)
were counted with an ocular micrometer (Xintu Photonics
Co., Ltd, Fuzhou, China). The experiment was performed
three times independently for each cell line.
Statistical analysis
Student’s t test was used to evaluate the significant dif-
ference between the two groups of data in all pertinent
experiments. P < 0.05 (Student’s t test) was considered
statistically significant.
Results
miR-582-5P is upregulated in CRC cells and tumor tissues
To investigate the function of miR-582-5P in the develop-
ment of human CRC, we analyzed the expression of miR-
582-5P in 218 CRC tumors and matched eight adjacent
noncancerous tissues with CRC tissues utilizing The Can-
cer Genome Atlas (TCGA) dataset. As shown in Fig. 1a,
miR-582-5P was significantly upregulated in the CRC
tumor tissues (P < 0.05). Furthermore, miR-582-5P was
significantly upregulated in the eight CRC tissue samples
as compared with the adjacent noncancerous colorectal
tissues (Fig. 1b). Real-time PCR showed that miR-582-5P
expression was markedly increased in the seven CRC cell
lines as compared with that in the normal colorectal epi-
thelial cells (Fig. 1c). Collectively, our results show that
miR-582-5P is overexpressed in the CRC cell lines and
tissues.
miR-582-5P overexpression induces cell proliferation
To investigate whether miR-582-5P plays a role in CRC
development and progression, we transfected SW480
cells with miR-582-5P mimic, miR-582-5P-in, NC, and
NC-in RNA. As shown in Fig. 2a, the SW480 cells were
successfully transfected with miR-582-5P. The MTT
assay was used to examine the effect of miR-582-5P
overexpression on the CRC cell proliferation and showed
that ectopic expression of miR-582-5P increased the cell
growth rate significantly (Fig. 2b). Furthermore, miR-
582-5P overexpression promoted SW480 cell proliferation
in the colony formation assay and anchorage-independent
growth assay (Fig. 2c, d). These results suggest that
miR-582-5P upregulation increases CRC cell prolifer-
ation in vitro.
Downregulation of miR-582-5P inhibits cell proliferation
Figure 3a shows that SW480 cells were successfully
transfected with miR-582-5P-in. The MTT assay demon-
strated that inhibiting miR-582-5P significantly reduced
SW480 cell growth (Fig. 3b). Furthermore, the downregu-
lation of miR-582-5P inhibited SW480 cell prolifera-
tion in the colony formation assay and anchorage-
independent growth assay (Fig. 3c, d). Consistent with
the findings depicted in Fig. 2, these results suggest
that miR-582-5P downregulation reduces CRC cell
proliferation in vitro.
miR-582-5P targets APC in CRC cells directly
To explore the molecular mechanism of miR-582-5P func-
tion in CRC cells, we used publicly available algorithms
(TargetScan, PicTar, miRanda) to predict miR-582-5P tar-
gets in humans. The results indicated that APC was a po-
tential target of miR-582-5P (Fig. 4a). As predicted, western
blotting showed that APC expression was decreased in
miR-582-5P-overexpressed SW480 cells and was increased
Fig. 1 miR-582-5P expression is upregulated in CRC. a miR-582-5P expression in 218 CRC tumors and eight matched adjacent noncancerous tissues
with CRC tissues based on the TCGA dataset. b Real-time PCR analysis of miR-582-5P expression in tumor tissues (T) and adjacent noncancerous tissues
(ANT) from eight patients with CRC. c Real-time PCR analysis of miR-582-5P expression in human normal colonic mucosal epithelial cells and CRC cells.
Mean miR-582-5P expression was normalized to U6 expression. Bars represent the mean ± SD of three independent experiments (*P < 0.05)
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in miR-582-5P-downregulated SW480 cells (Fig. 4b). Mean-
while, the results of COLO205 were similar with that of
SW480 (Additional file 1: Figure S1).To examine whether
miR-582-5P-mediated APC downregulation occurred via
the 3′ UTR of APC, we subcloned the APC 3′ UTR frag-
ment, containing a miR-582-5P binding site, into a pGL3
luciferase reporter vector. miR-582-5P overexpression
reduced the luciferase reporter activity of the APC 3′
UTR consistently and dose-dependently; miR-582-5P in-
hibition had the opposite effect. However, APC 3′ UTR
luciferase reporter activity was unaffected by point muta-
tions in the miR-582-5P-binding seed region (Fig. 4c). Col-
lectively, our results suggest that APC is a direct target of
miR-582-5P.
Fig. 2 Ectopic miR-582-5P expression induces CRC cell proliferation. a Real-time PCR analysis confirming that SW480 cells were successfully transfected
with miR-582-5P mimic or NC (negative control) RNA. b MTT assay analysis of the effects of ectopic miR-582-5P expression on CRC cell proliferation.
c Ectopic overexpression of miR-582-5P promoted the colony formation ability of SW480 cells. Representative micrographs (left) and quantification
(right) of crystal violet-stained cell colonies at 10 days after transfection. d Anchorage-independent growth assay demonstrating that ectopic
overexpression of miR-582-5P promoted SW480 cell tumorigenicity. Shown are representative micrographs (left) and quantification of colonies
>0.1 mm (right). Bars represent the mean ± SD of three independent experiments (*P < 0.05)
Fig. 3 Downregulation of miR-582-5P inhibits CRC cell proliferation. a Real-time PCR analysis confirming that SW480 cells were successfully transfected with
miR-582-5P-in or NC (negative control) RNA. b MTT assay demonstrating that miR-582-5P downregulation reduced SW480 cell proliferation. c Downregulation
of miR-582-5P reduced the colony formation ability of SW480 cells. Shown are representative micrographs (left) and quantification (right)
of crystal violet-stained cell colonies at 10 days after transfection. d Anchorage-independent growth assay demonstrating that miR-582-5P
downregulation reduced the tumorigenicity of SW480 cells. Shown are representative micrographs (left) and quantification of colonies >0.1 mm (right).
Bars represent the mean ± SD of three independent experiments (*P < 0.05)
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Subsequently, real-time PCR demonstrated that miR-
582-5P overexpression significantly increased the expres-
sion of cyclin D1 and c-MYC mRNA in SW480 cells
(Fig. 4d). Additionally, the western blotting results were
consistent with the real-time PCR data (Fig. 4e). These
findings indicate that miR-582-5P may play an important
role in regulating the proliferation of CRC cells.
miR-582-5P induces SW480 cell proliferation in an APC-
dependent manner
We determined the effect of miR-582-5P repression in
SW480 cells based on the hypothesis that APC repres-
sion by miR-582-5P may lead to cell proliferation. We
repressed endogenous APC expression using an APC-
specific small interfering RNA (siRNA) (Fig. 5a). The
colony formation assay and anchorage-independent
growth assay both showed that silencing APC in miR-
582-5P-in-transfected cells increased cell proliferation
(Fig. 5b, c). Together, our results suggest that miR-582-
5P may repress APC expression and further promote
CRC progression. However, the silenced APC expres-
sion, and its effect on cell proliferation, is reversed in
miR-582-5P-in-transfected cells. These data show that
miR-582-5P induces SW480 cell proliferation by repres-
sing APC expression and that APC may play an import-
ant role in miR-582-5P-mediated cell proliferation.
Discussion
microRNAs, a class of small regulatory RNA molecules that
negatively regulate their mRNA targets in a sequence-
specific manner, play important roles in multiple biological
processes such as cell differentiation, proliferation, onco-
genesis, angiogenesis, invasion, and metastasis and may
function as either tumor suppressors or oncogenes [18–20].
Uchino et al. found that miR-582-5P reduced human blad-
der cancer proliferation and invasion by suppressing the
Fig. 4 miR-582-5P targets the 3′ UTR of APC mRNA directly. a Schematic representation of mature miR-582-5P sequence and miR-582-5P target
sites of the 3′ UTR of APC mRNA (red) and the 3′ UTR of APC mutant mRNA containing three altered nucleotides (green) in the putative target site
(APC-3′ UTR-mut). b Western blotting analysis of APC (300KD) expression in SW480 cells transfected with miR-582-5P or miR-582-5P-in as compared to NC
cells. c Luciferase assay of pGL3-APC-3′ UTR reporter co-transfected with 10 or 50 nM miR-582-5P mimic, miR-582-5P-in, or miR-582-5P-mut (pGL3-APC-3′
UTR) in SW480 cells. d, e Real-time PCR (d) and western blotting (e) analysis of cyclin D1 (cyclin D1, 34KD) and c-MYC (c-MYC, 53KD) mRNA expression in
SW480 cells transfected with miR-582-5P mimic or miR-582-5P-in. Bars represent the mean ± SD of three independent experiments (*P< 0.05)
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expression of target genes such as PGGT1B, LRRK2, and
DIXDC1 [16]. Furthermore, Floyd et al. found that miR-
582-5P directly targeted caspase 3 (CASP3), caspase 9
(CASP9), and BIM, consequently influencing glioblastoma
cell survival [21]. Liu et al. suggested that miR-582-5P can
inhibit monocyte apoptosis by downregulating forkhead
box O1 (FOXO1) expression and that it plays an important
role in regulating anti-Mycobacterium tuberculosis-directed
immune responses [22]. However, there has been no re-
search on the role of miR-582-5P in CRC progression. In
our study, we found that miR-582-5P was significantly
overexpressed in CRC cells as compared to normal co-
lonic mucosa epithelial cells. Additionally, miR-582-5P
was upregulated in CRC tissues when compared with the
matched adjacent noncancerous tissues. Furthermore, ec-
topic expression of miR-582-5P significantly increased cell
growth, while inhibiting miR-582-5P had the opposite ef-
fect. These results indicate that upregulation of miR-582-
5P may correlate with the progression of CRC and that
miR-582-5P may function as an onco-miRNA in CRC.
Mutations in APC are believed to be one of the earliest
events that contribute to CRC initiation. APC I1307K
germline mutation is the most common and important
mutation. Firstly, the APC I1307K germline mutation is
associated with increased risk for CRC development,
tumor location, and tumor stage [23]. Secondly, compared
with non-carriers, APC I1307K carriers had increased
numbers of adenomas and tumors per patient, as well as
younger age at diagnosis. The APC I1307K allele is associ-
ated with an estimated relative risk of 1.5–1.7 for colorec-
tal neoplasia [24]. However, Figer et al. suggested that
these mutations contribute little to disease pathogenesis
[25, 26]. In addition, methylation of the APC gene pro-
moter region in cancerous tissue in combination with the
predominance of methylation in normal tissue may serve
as a prognostic factor in patients with CRC [27, 28]. In this
study, we used three methods to confirm that APC is a
predicted target gene of miR-582-5P. Western blotting
showed that overexpression of miR-582-5P downregulated
APC protein expression but upregulated cyclin D1 and c-
MYC expression. The luciferase activity assay and point
mutation analysis demonstrated that APC downregulation
was mediated by miR-582-5P specifically targeting the
APC 3′ UTR. The mechanism of miR-582-5P induction of
cell proliferation is currently under investigation in our
laboratory.
Conclusions
Our results show that miR-582-5P is markedly upregu-
lated in the CRC cells and clinical tissues as compared
with matched adjacent noncancerous tissues from the
same patient. Furthermore, APC is a direct target gene
of miR-582-5P, and overexpression of miR-582-5P re-
duced the expression of APC and inhibited CRC cell
proliferation, whereas downregulation had the opposite
effect. Further investigation is required to fully
characterize the biological function of miR-582-5P and
its clinical relevance in the development of CRC. Col-
lectively, although the precise mechanisms are not yet
fully understood, this finding suggests that miR-582-5P
may play an important role in regulating the prolifera-
tion of CRC cells and represent a therapeutic target for
colorectal cancer.
Additional file
Additional file 1: Figure S1. Real-time PCR (left) and western blotting
analysis (right) of APC expression in COLO205 cells transfected with miR-582-
5P or miR-582-5P-in as compared to NC cells. (TIF 109 kb)
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